文献速递生殖医学

黄体期起始阴道微粒化黄体酮改善复发性妊娠丢失妇女的妊娠成功

Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss.
PubMed 文献 · Fertil Steril · 2017-01-09

该观察性队列研究纳入2004至2012年间有两次及以上不明原因妊娠丢失(<10周)且后续有妊娠的妇女,根据子宫内膜活检nCyclinE表达决定是否从LH峰后3天起始阴道微粒化黄体酮100-200 mg每12小时一次。nCyclinE升高组干预后妊娠成功率由既往6%(16/255)升至69%(57/83);用药组后续妊娠成功率68%(86/126)高于对照组51%(19/37),OR=2.1(95%CI 1.0-4.4)。

要点

  • nCyclinE升高组干预后妊娠成功率由6%(16/255)升至69%(57/83)。
  • 用药组后续妊娠成功率68%(86/126) vs 对照组51%(19/37),OR=2.1(95%CI 1.0-4.4)。
  • 黄体期起始阴道微粒化黄体酮与严格定义的RPL队列妊娠成功改善相关。

核心结论

  • 在严格定义的复发性妊娠丢失队列中,黄体期起始阴道微粒化黄体酮的使用与妊娠成功改善相关。

研究设计与样本

  • 观察性队列研究,使用前瞻性收集的数据。
  • 纳入2004至2012年间有两次及以上不明原因妊娠丢失(<10周)且后续有一次或以上妊娠的妇女,LH峰后9-11天行子宫内膜活检;排除活检发现子宫内膜炎、成熟延迟或腺体-间质不同步者。
  • 共116名妇女符合纳入标准,其中51%(n=59)nCyclinE升高,49%(n=57)nCyclinE正常。

主要发现

  • nCyclinE升高组59名妇女干预后妊娠成功显著改善:既往妊娠6%(16/255) vs 后续妊娠69%(57/83)。
  • 用药组后续妊娠成功率68%(86/126) vs 对照组51%(19/37),OR=2.1(95%CI 1.0-4.4)。

关键数值与推荐

  • nCyclinE升高定义为子宫内膜腺体腺上皮核cyclin E表达>20%;正常定义为≤20%。
  • 阴道微粒化黄体酮剂量100-200 mg,每12小时一次,LH峰后3天(黄体期)起始。
  • 妊娠成功定义为持续妊娠>10周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effectiveness of luteal start vaginal micronized P in a recurrent pregnancy loss (RPL) cohort. DESIGN: Observational cohort study using prospectively collected data. SETTING: Not applicable. PATIENT(S): Women seen between 2004 and 2012 with a history of two or more unexplained pregnancy losses <10 weeks in size; endometrial biopsy (EB) performed 9-11 days after LH surge; and one or more subsequent pregnancy(ies). Women were excluded if concomitant findings, such as endometritis, maturation delay, or glandular-stromal dyssynchrony, were identified on EB. INTERVENTION(S): Vaginal micronized P was prescribed at a dose of 100-200 mg every 12 hours starting 3 days after LH surge (luteal start) if glandular epithelial nuclear cyclin E (nCyclinE) expression was elevated (>20%) in endometrial glands or empirically despite normal nCyclinE (≤20%). Women with normal nCyclinE (≤20%) who did not receive P were used as controls. MAIN OUTCOME MEASURE(S): Pregnancy success was an ongoing pregnancy >10 weeks in size. RESULT(S): One hundred sixteen women met the inclusion criteria, of whom 51% (n = 59) had elevated nCyclinE and 49% (n = 57) had normal nCyclinE. Pregnancy success in the 59 women with elevated nCyclinE significantly improved after intervention: 6% (16/255) in prior pregnancies versus 69% (57/83) in subsequent pregnancies. Pregnancy success in subsequent pregnancies was higher in women prescribed vaginal micronized P compared with controls: 68% (86/126) versus 51% (19/37); odds ratio = 2.1 (95% confidence interval, 1.0-4.4). CONCLUSION(S): In this study, we found that the use of luteal start vaginal micronized P was associated with improved pregnancy success in a strictly defined cohort of women with RPL.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Stephenson MD, McQueen D, Winter M, et al. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss. Fertil Steril. 2017. PMID: 28081870. doi:10.1016/j.fertnstert.2016.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。